Cutaneous reactions with tenofovir disoproxil fumarate: a report of nine cases
- 1 June 2007
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 21 (10) , 1370-1373
- https://doi.org/10.1097/qad.0b013e32811ebf9e
Abstract
Adverse drug reactions causing the early discontinuation of therapy are common in patients with HIV infection. Hypersensitivity consisting mainly of a maculopapular rash on the face, extremities and trunk has been observed at a rate higher than expected in patients treated with tenofovir at our clinics. We therefore examined nine patients with suspected tenofovir hypersensitivity reactions in two indigent care HIV clinics. Type I and type IV hypersensitivity may be involved as immunological mechanisms.Keywords
This publication has 6 references indexed in Scilit:
- Patterns and Correlates of Discontinuation of the Initial HAART Regimen in an Urban Outpatient CohortJAIDS Journal of Acquired Immune Deficiency Syndromes, 2003
- A Comprehensive Hepatic Safety Analysis of Nevirapine in Different Populations of HIV Infected Patients*JAIDS Journal of Acquired Immune Deficiency Syndromes, 2003
- Sex Differences in Nevirapine RashClinical Infectious Diseases, 2001
- Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infectionAIDS, 2000
- Hepatotoxicity Associated With Antiretroviral Therapy in Adults Infected With Human Immunodeficiency Virus and the Role of Hepatitis C or B Virus InfectionJAMA, 2000
- Cutaneous Disease and Drug Reactions in HIV InfectionNew England Journal of Medicine, 1993